Literature DB >> 27872905

Interferon-driven deletion of antiviral B cells at the onset of chronic infection.

Benedict Fallet1, Kerstin Narr1, Yusuf I Ertuna1, Melissa Remy1, Rami Sommerstein2, Karen Cornille1, Mario Kreutzfeldt2,3, Nicolas Page2, Gert Zimmer4, Florian Geier5, Tobias Straub6, Hanspeter Pircher6, Kevin Larimore7,8, Philip D Greenberg7,8, Doron Merkler2,3, Daniel D Pinschewer1.   

Abstract

Inadequate antibody responses and perturbed B cell compartments represent hallmarks of persistent microbial infections, but the mechanisms whereby persisting pathogens suppress humoral immunity remain poorly defined. Using adoptive transfer experiments in the context of a chronic lymphocytic choriomeningitis virus (LCMV) infection of mice, we have documented rapid depletion of virus-specific B cells that coincided with the early type I interferon response to infection. We found that the loss of activated B cells was driven by type I interferon (IFN-I) signaling to several cell types including dendritic cells, T cells and myeloid cells. Intriguingly, this process was independent of B cell-intrinsic IFN-I sensing and resulted from biased differentiation of naïve B cells into short-lived antibody-secreting cells. The ability to generate robust B cell responses was restored upon IFN-I receptor blockade or, partially, when experimentally depleting myeloid cells or the IFN-I-induced cytokines interleukin 10 and tumor necrosis factor alpha. We have termed this IFN-I-driven depletion of B cells "B cell decimation". Strategies to counter "B cell decimation" should thus help us better leverage humoral immunity in the combat against persistent microbial diseases.

Entities:  

Year:  2016        PMID: 27872905      PMCID: PMC5115616          DOI: 10.1126/sciimmunol.aah6817

Source DB:  PubMed          Journal:  Sci Immunol        ISSN: 2470-9468


  66 in total

1.  Parameters governing exhaustion of rare T cell-independent neutralizing IgM-producing B cells after LCMV infection.

Authors:  Raphaël M Zellweger; Lars Hangartner; Jacqueline Weber; Rolf M Zinkernagel; Hans Hengartner
Journal:  Eur J Immunol       Date:  2006-12       Impact factor: 5.532

2.  B lymphocyte-specific, Cre-mediated mutagenesis in mice.

Authors:  R C Rickert; J Roes; K Rajewsky
Journal:  Nucleic Acids Res       Date:  1997-03-15       Impact factor: 16.971

3.  Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen.

Authors:  H Pircher; K Bürki; R Lang; H Hengartner; R M Zinkernagel
Journal:  Nature       Date:  1989-11-30       Impact factor: 49.962

4.  Transcriptional profiling of mouse B cell terminal differentiation defines a signature for antibody-secreting plasma cells.

Authors:  Wei Shi; Yang Liao; Simon N Willis; Nadine Taubenheim; Michael Inouye; David M Tarlinton; Gordon K Smyth; Philip D Hodgkin; Stephen L Nutt; Lynn M Corcoran
Journal:  Nat Immunol       Date:  2015-04-20       Impact factor: 25.606

5.  Blockade of chronic type I interferon signaling to control persistent LCMV infection.

Authors:  Elizabeth B Wilson; Douglas H Yamada; Heidi Elsaesser; Jonathan Herskovitz; Jane Deng; Genhong Cheng; Bruce J Aronow; Christopher L Karp; David G Brooks
Journal:  Science       Date:  2013-04-12       Impact factor: 47.728

6.  Interleukin-10-deficient mice develop chronic enterocolitis.

Authors:  R Kühn; J Löhler; D Rennick; K Rajewsky; W Müller
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

7.  Reversal of chronic to resolved infection by IL-10 blockade is LCMV strain dependent.

Authors:  Kirsten Richter; Guillaume Perriard; Annette Oxenius
Journal:  Eur J Immunol       Date:  2013-01-25       Impact factor: 5.532

8.  An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis.

Authors:  Matthew P R Berry; Christine M Graham; Finlay W McNab; Zhaohui Xu; Susannah A A Bloch; Tolu Oni; Katalin A Wilkinson; Romain Banchereau; Jason Skinner; Robert J Wilkinson; Charles Quinn; Derek Blankenship; Ranju Dhawan; John J Cush; Asuncion Mejias; Octavio Ramilo; Onn M Kon; Virginia Pascual; Jacques Banchereau; Damien Chaussabel; Anne O'Garra
Journal:  Nature       Date:  2010-08-19       Impact factor: 49.962

9.  Nonneutralizing antibodies binding to the surface glycoprotein of lymphocytic choriomeningitis virus reduce early virus spread.

Authors:  Lars Hangartner; Raphaël M Zellweger; Mattia Giobbi; Jacqueline Weber; Bruno Eschli; Kathy D McCoy; Nicola Harris; Mike Recher; Rolf M Zinkernagel; Hans Hengartner
Journal:  J Exp Med       Date:  2006-07-31       Impact factor: 14.307

10.  Alterations in peripheral blood B cell subsets and dynamics of B cell responses during human schistosomiasis.

Authors:  Lucja A Labuda; Ulysse Ateba-Ngoa; Eliane Ngoune Feugap; Jorn J Heeringa; Luciën E P M van der Vlugt; Regina B A Pires; Ludovic Mewono; Peter G Kremsner; Menno C van Zelm; Ayola A Adegnika; Maria Yazdanbakhsh; Hermelijn H Smits
Journal:  PLoS Negl Trop Dis       Date:  2013-03-07
View more
  45 in total

1.  Regulation of CD4 T cells and their effects on immunopathological inflammation following viral infection.

Authors:  Mitra Bhattacharyya; Patrick Madden; Nathan Henning; Shana Gregory; Malika Aid; Amanda J Martinot; Dan H Barouch; Pablo Penaloza-MacMaster
Journal:  Immunology       Date:  2017-07-14       Impact factor: 7.397

2.  Infection: Interferons suppress antibody responses.

Authors:  Elisabeth Kugelberg
Journal:  Nat Rev Immunol       Date:  2016-11-25       Impact factor: 53.106

Review 3.  CD4+ T Cell Differentiation in Chronic Viral Infections: The Tfh Perspective.

Authors:  Laura A Vella; Ramin S Herati; E John Wherry
Journal:  Trends Mol Med       Date:  2017-11-12       Impact factor: 11.951

4.  IL-12 Blocks Tfh Cell Differentiation during Salmonella Infection, thereby Contributing to Germinal Center Suppression.

Authors:  Rebecca A Elsner; Mark J Shlomchik
Journal:  Cell Rep       Date:  2019-11-26       Impact factor: 9.423

5.  Chronic Lymphocytic Choriomeningitis Infection Causes Susceptibility to Mousepox and Impairs Natural Killer Cell Maturation and Function.

Authors:  Pedro Alves-Peixoto; Maria Férez; Cory J Knudson; Colby Stotesbury; Carolina R Melo-Silva; Eric B Wong; Margarida Correia-Neves; Luis J Sigal
Journal:  J Virol       Date:  2020-02-14       Impact factor: 5.103

Review 6.  The role of type I interferons in CD4+ T cell differentiation.

Authors:  Mirela Kuka; Marco De Giovanni; Matteo Iannacone
Journal:  Immunol Lett       Date:  2019-02-13       Impact factor: 3.685

Review 7.  In vivo imaging of adaptive immune responses to viruses.

Authors:  Marco De Giovanni; Matteo Iannacone
Journal:  Curr Opin Virol       Date:  2017-12-26       Impact factor: 7.090

8.  Type I and Type III Interferons Differ in Their Adjuvant Activities for Influenza Vaccines.

Authors:  Liang Ye; Annette Ohnemus; Li Ching Ong; Hans Henrik Gad; Rune Hartmann; Nils Lycke; Peter Staeheli
Journal:  J Virol       Date:  2019-11-13       Impact factor: 5.103

9.  Efficient control of chronic LCMV infection by a CD4 T cell epitope-based heterologous prime-boost vaccination in a murine model.

Authors:  Ran He; Xinxin Yang; Cheng Liu; Xiangyu Chen; Lin Wang; Minglu Xiao; Jianqiang Ye; Yuzhang Wu; Lilin Ye
Journal:  Cell Mol Immunol       Date:  2017-03-13       Impact factor: 11.530

Review 10.  The Role of Interferon in Persistent Viral Infection: Insights from Murine Norovirus.

Authors:  Timothy J Nice; Bridget A Robinson; Jacob A Van Winkle
Journal:  Trends Microbiol       Date:  2017-11-17       Impact factor: 17.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.